Sign up to receive updates, news, and more.
RockGen is a start-up biotechnology company with innovative goals to develop efficacious treatments for patients suffering from neurodegenerative diseases. We utilize cutting-edge research in our investigation of the diseases of the central nervous system for developing novel and disease-modifying medicine. Amyotrophic Lateral Sclerosis will be our first to develop an effective therapy.
At RockGen we use proprietary compounds and their evaluations in pre-clinical models of central nervous system diseases. The main goal is to develop efficacious compounds as drugs for testing in clinical trials.
At RockGen we use innovative chemistry to develop pro-drugs and analogs using wet laboratory and in silico systems to expand our pipelines and expedite drug development.